Combining best-in-class AI-powered Technologies for Musculoskeletal (MSK) Imaging Workflows - ImageBiopsy Lab and Radiobotics sign Collaboration Agreement
22 Sep 2023
VIENNA, Sept. 22, 2023 /PRNewswire/ -- ImageBiopsy Lab (Vienna, Austria) and Radiobotics (Copenhagen, Denmark) have teamed up to advance the use of Artificial-Intelligence (AI) supported disease diagnostics for musculoskeletal (MSK), orthopaedic, and trauma use-cases in the DACH region.
Globally, musculoskeletal conditions affect a larger population than circulatory or respiratory disorders. Despite this, diagnostic methods often remain rooted in outdated practices, relying on manual interpretation of X-rays and MRI images. These subjective and time-intensive techniques lack standardisation and depend on practitioner expertise.
Despite a growing number of MSK-specific solutions, users lack a holistic answer for diverse diagnostic needs. With their collaboration ImageBiopsy Lab and Radiobotics (both with MDR and FDA clearances) will merge their expertise and provide a single, comprehensive solution for MSK imaging, encompassing measurement, scoring, and fracture detection workflow.
Dr. Richard Ljuhar, CEO and Co-Founder of ImageBiopsy Lab, explains, "Before even considering the use of AI, it's crucial to grasp physicians' diagnostic workflow and needs. For this purpose we've closely collaborated with leading MSK radiologists, orthopaedics, and traumatologists over the past years. We're committed to revolutionizing the entire MSK diagnostic value chain for practitioners, patients, and healthcare systems.
We see Radiobotics as the logical partner to offer best in class solutions for MSK conditions diagnostics, from measurements and scoring to fracture detection. Our collaboration marks the next AI-powered workflow integration phase.
Mads Jarner, CEO and Co-founder of Radiobotics, notes, "As MSK AI solutions gain traction in clinical workflows, providing clinics with integrated and comprehensive options becomes vital. We're thrilled to collaborate with ImageBiopsy Lab to facilitate access to our market-leading solutions. Leveraging ImageBiopsy Lab's expertise and network in German-speaking regions, we're excited to introduce our RBfracture™ fracture detection solution in this area initially, with potential expansion to other regions.
About
ImageBiopsy Lab and Radiobotics are both considered pioneers in the field of deep learning technology applied to musculoskeletal imaging analysis. Over the course of their development, the two award-winning companies have progressively specialised in distinct areas. ImageBiopsy Lab excels with a comprehensive portfolio of automated measurement solutions, while Radiobotics leads in fracture detection. By joining forces, they aim to cover the complete spectrum of radiologists' and orthopaedics' needs.
For media inquiries: Annalisa Blaha, marketing@imagebiopsy.com, +43 1905 12061104
Photo -
Logo -
View original content to download multimedia:
SOURCE ImageBiopsy Lab
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
-Indications
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.